St. Jude Medical Received FDA Approval For New Therapy To Treat Chronic Intractable Pain Of The Limbs

By: via Benzinga
Shares of St. Jude Medical, Inc. (NYSE: STJ) were trading higher by nearly 2 percent on Wednesday after the company announced the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.